Fundraising Fox

VQ Biomedical

Apex, US · Founded 2023 · Delaware corporation · 3 known investors

Biotech

Founders & leadership

MD
MARC DESHUSSESNamed on SEC filing
TS
TOBIAS STRAUBENamed on SEC filing
GR
GALEN ROBERTSONNamed on SEC filing

Board

DE
Daniel E. EstayBoard director
JK
JOE KNIGHTBoard director

Investors · 3

Duke Capital PartnersDurham
Wolfpack Investor NetworkRaleigh · $250K – $5M
DCPreported · 2 sources

Reported raises · per SEC filings

Form D private placements

$1.6M disclosed across 1 round · 2024

▶$1.6MraisedMar 2025 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MARC DESHUSSESDirector
  • TOBIAS STRAUBEExecutive Officer, Director
  • Daniel E. EstayDirector
  • GALEN ROBERTSONExecutive Officer, Director
  • JOE KNIGHTDirector
Offering amount
$1.6M
Amount sold
$1.6M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap
Cqmedical11 shared keywordsCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
Bioworld8 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Vektor Medical7 shared keywordsVektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias. Its technology targets electrophysiologists and cardiologists working in cardiac rhythm management.
Mobiamedical6 shared keywordsMobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.

Companies competing with VQ Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

VQ Biomedical: $5 Million (Seed) Raised For Duke University Medical Tech Spin-Outpulse2.com · Apr 2025VQ Biomedical | Wolfpack Investor Networkresearch.ncsu.edu · Mar 2025VQ Biomedical secures $5M, including a seed round led by Harbright, WIN, and DCP - Duke Capital Partnersdukecapitalpartners.duke.edu · Mar 2025WIN and Harbright Raise $770K for VQ Biomedical | Wolfpack Investor Networkresearch.ncsu.edu · Mar 2025VQ Biomedical raises $5M to develop safer, simpler lung-injury treatment - Axios Raleighaxios.com · Mar 2025VQ Biomedical raises $5M for a new treatment for lung injuries | Wolfpack Investor Networkresearch.ncsu.edu · Mar 2025

Frequently asked questions

Who are VQ Biomedical's investors?
VQ Biomedical's investors include Duke Capital Partners, Wolfpack Investor Network, DCP.
How much funding has VQ Biomedical raised?
VQ Biomedical has disclosed $1.6M raised across 1 round.
Where is VQ Biomedical headquartered?
VQ Biomedical is headquartered in Apex, US.